Boardman. Neonatología_8ed

136

PARTE 2 • El feto como paciente

179. Bruner JP, Tulipan N, Paschall RL, et al. Intrauterine repair of myelome‑ ningocele, “hindbrain restoration” and the incidence of shunt‑dependent hydrocephalus. JAMA 1999;282:1826. 180. Adzick NS, Thom EA, Spong CV, et al. A randomized trial of prenatal ver‑ sus postnatal repair of myelomeningocele. N Engl J Med 2011;364:993. 181. Joyeux L, Engels AC, Russo FM, et al. Fetoscopic versus open repair for spina bifida aperta: a systematic review of outcomes. Fetal Diagn Ther 2016;39:161. 182. Committee on Obstetric Practice, Society for Maternal–Fetal Medicine. Committee Opinion No. 720: Maternal‑Fetal Surgery for Myelomeningo‑ cele. Obstet Gynecol 2017;130:e164. 183. Moldenhauer JS. Ex utero intrapartum therapy. Semin Pediatr Surg 2013;22:44. 184. Czeizel AE, Dudas I. Prevention of the first occurrence of neural‑tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832. 185. Evans MI, Llurba E, Landsberger EJ, et al. Impact of folic acid supplemen‑ tation in the United States: markedly diminished high maternal serum AFPs. Obstet Gynecol 2004;103:474. 186. Dolin CD, Deierlein AL, Evans MI. Folic acid supplementation to pre‑ vent recurrent neural tube defects: 4 mg is too much. Fetal Diagn Ther 2018;44:161. 187. Evans MI, Chrousos GP, Mann DL, et al. Pharmacologic suppression of the fetal adrenal gland in utero: attempted prevention of abnormal exter‑ nal genital masculinization in suspected congenital adrenal hyperplasia. JAMA 1985;253:1015. 188. New M, Abraham M, Yuen T, et al. An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia. Semin Reprod Med 2012;30:396. 189. Heland S. Preventing female virilisation in congenital adrenal hyperpla‑ sia: The controversial role of antenatal dexamethasone. Aust N Z J Obstet Gynaecol 2016;56:225. 190. Evans MI, Duquette DA, Rinaldo P, et al. Modulation of B12 dosage and response in fetal treatment of methylmalonic aciduria (MMA); Titration of treatment dose to serum and urine MMA. Fetal Diagn Ther 1997;12:21. 191. Flake AW, Puck JM, Almieda‑Porada G, et al. Successful in utero correc‑ tion of X‑linked recessive severe combined immuno‑deficiency (X‑SCID): fetal intraperitoneal transplantation of CD34 enriched paternal bone marrow cells (EPPBMC). N Engl J Med 1996;335:871. 192. Pearson EG, Flake AW. Stem cell and genetic therapies for the fetus. Semin Pediatr Surg 2013;22:56.

162. Evans MI, Goldberg J, Horenstein J, et al. Selective termination (ST) for structural (STR), chromosomal (CHR), and Mendelian (MEN) anomalies: international experience. Am J Obstet Gynecol 1999;181(4):893. 163. Hack KE, Derks JB, Elias SG, et al. Increased perinatal mortality and morbidity in monochorionic versus dichorionic twin pregnancies: clini‑ cal implications of a large Dutch cohort study. BJOG 2008;115:58. 164. Evans MI, Lau TK. Making decisions when no good options exist: delivery of the survivor after intrauterine death of the co‑twin in monochorionic twin pregnancies. Fetal Diagn Ther 2010;28:191. 165. Quintero RA, Reich H, Puder KS, et al. Brief report: umbilical cord liga‑ tion of an acardiac twin by fetoscopy at 19 weeks of gestation. N Engl J Med 1994;330:469. 166. Gebb J, Rosner M, Dar P, et al. Long term neurologic outcomes after fetal interventions: meta‑analysis. Am J Obstet Gynecol 2014;210:S115. 167. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963;2 1107. 168. Manning FA, Harrison MR, Rodeck C. Catheter shunts for fetal hydrone‑ phrosis and hydrocephalus. Report of the international fetal surgery reg‑ istry. N Engl J Med 1986;315:336. 169. Evans MI, Sacks AL, Johnson MP, et al. Sequential invasive assessment of fetal renal function, and the in utero treatment of fetal obstructive uropa‑ thies. Obstet Gynecol 1991:77:545. 170. Wu S, Johnson MP. Fetal lower urinary tract obstruction. Clin Perinatol 2009;36:377. 171. Munoz J, Kessler AA, Felig P, et al. Sequential amniotic fluid thyroid hor‑ mone changes correlate with goiter shrinkage following in utero thyrox‑ ine therapy. Fetal Diagn Ther 2016;39:222. 172. Senat MV, Deprest J, Boulvain M, et al. Endoscopic laser surgery ver‑ sus serial amnioreduction for severe twin to twin transfusion syndrome. N Engl J Med 2004;351:136. 173. Papanna R. Twin-twin transfusion syndrome: management and out come . Up to date.com. Available from: https://www.uptodate.com/ contents/twin‑twin‑transfusion‑syndrome‑management‑and‑outcome/ print 174. Quintero RA, Morales WJ, Allen MH, et al. Staging of twin‑twin transfu‑ sion syndrome. J Perinatol 1999;19:550. 175. Harrison MR, Longaker MT, Adzick NS, et al. Successful repair in utero of a fetal diaphragmatic hernia after removal of herniated viscera from the left thorax. N Engl J Med 1990;322:1582. 176. Harrison MR, Evans MI, Adzick NS, et al., eds. The unborn patient: the art and science of fetal therapy , 3rd ed. Philadelphia, PA: W.B. Saunders Publishing Company, 2001. 177. Hedrick HL. Management of prenatally diagnosed congenital diaphrag‑ matic hernia. Semin Pediatr Surg 2013;22:37. 178. Egloff A, Bulas DI. Prenatal diagnosis and management of congenital pul‑ monary airway malformation. Available from: https://www.uptodate.com/ contents/prenatal‑diagnosis‑and‑management‑of‑congenital‑pulmonary‑ airway‑malformation

193. Riley JS, McClain LE, Stratigis JD, et al. Pre‑existing maternal antibod‑ ies cause rapid prenatal rejection of allotransplants in mouse model of in utero hematopoietic cell transplantation. J Immunol 2018;201:1549. 194. Moon‑Grady AJ, Baschat A, Cass D, et al. Fetal Treatment 2017: the evo‑ lution of fetal therapy centers—a joint opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFNet). Fetal Diagn Ther 2017;42:241. SAMPLE